ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.
NEW YORK, July 24, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors concerning the proposed acquisition of the company by Palvella Therapeutics, Inc. Pieris Pharmaceuticals stockholders are expected to own approximately 18% of the combined company. The transaction is expected to close in the fourth quarter of 2024.
罗利律师事务所正在调查Pieris Pharmaceuticals, Inc.（纳斯达克:PIRS）及其董事会因被Palvella Therapeutics, Inc. 收购提议涉嫌潜在证券法违规问题。Pieris Pharmaceuticals股东预计将持有合并后公司的约18％。交易预计将于2024年第四季度关闭。
If you are a stockholder of Pieris Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: /. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
如果您是Pieris Pharmaceuticals，Inc.的股东，并且有兴趣获取有关此调查的其他信息，请访问我们：/。您也可以通过电子邮件与Shane Rowley律师联系，地址为：纽约州怀特普莱恩斯市50 Main Street Suite 1000。[email protected]。
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit .
Rowley Law PLLC代表全国股东参与复杂企业诉讼中的集体诉讼和衍生诉讼。有关该公司及其律师的更多信息，请访问 .
Attorney Advertising. Prior results do not guarantee a similar outcome.
律师广告。之前的结果不能保证类似的结果。
SOURCE Rowley Law PLLC
消息来源：Rowley Law PLLC